BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 17135446)

  • 1. Pathological role of Toll-like receptor signaling in cerebral malaria.
    Coban C; Ishii KJ; Uematsu S; Arisue N; Sato S; Yamamoto M; Kawai T; Takeuchi O; Hisaeda H; Horii T; Akira S
    Int Immunol; 2007 Jan; 19(1):67-79. PubMed ID: 17135446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine cerebral malaria development is independent of toll-like receptor signaling.
    Togbe D; Schofield L; Grau GE; Schnyder B; Boissay V; Charron S; Rose S; Beutler B; Quesniaux VF; Ryffel B
    Am J Pathol; 2007 May; 170(5):1640-8. PubMed ID: 17456769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
    Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ
    Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brucella abortus induces Irgm3 and Irga6 expression via type-I IFN by a MyD88-dependent pathway, without the requirement of TLR2, TLR4, TLR5 and TLR9.
    Lapaque N; Muller A; Alexopoulou L; Howard JC; Gorvel JP
    Microb Pathog; 2009 Dec; 47(6):299-304. PubMed ID: 19747534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury.
    Velayudham A; Hritz I; Dolganiuc A; Mandrekar P; Kurt-Jones E; Szabo G
    J Hepatol; 2006 Dec; 45(6):813-24. PubMed ID: 16935388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host.
    Griffith JW; O'Connor C; Bernard K; Town T; Goldstein DR; Bucala R
    J Infect Dis; 2007 Nov; 196(10):1553-64. PubMed ID: 18008236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria.
    Belnoue E; Potter SM; Rosa DS; Mauduit M; Grüner AC; Kayibanda M; Mitchell AJ; Hunt NH; Rénia L
    Parasite Immunol; 2008 Oct; 30(10):544-53. PubMed ID: 18665903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MyD88 is dispensable for resistance to Paracoccidioides brasiliensis in a murine model of blood-borne disseminated infection.
    González A; Yáñez A; Gozalbo D; Gil ML
    FEMS Immunol Med Microbiol; 2008 Dec; 54(3):365-74. PubMed ID: 19049649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif.
    Lichtnekert J; Vielhauer V; Zecher D; Kulkarni OP; Clauss S; Segerer S; Hornung V; Mayadas TN; Beutler B; Akira S; Anders HJ
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F867-74. PubMed ID: 19158348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori.
    Rad R; Brenner L; Krug A; Voland P; Mages J; Lang R; Schwendy S; Reindl W; Dossumbekova A; Ballhorn W; Wagner H; Schmid RM; Bauer S; Prinz C
    Gastroenterology; 2007 Jul; 133(1):150-163.e3. PubMed ID: 17631139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation.
    Zhou Z; Hoebe K; Du X; Jiang Z; Shamel L; Beutler B
    Eur J Immunol; 2005 Jun; 35(6):1918-27. PubMed ID: 15884053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
    Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program.
    Negishi H; Fujita Y; Yanai H; Sakaguchi S; Ouyang X; Shinohara M; Takayanagi H; Ohba Y; Taniguchi T; Honda K
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15136-41. PubMed ID: 17018642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic zebrafish reporter lines reveal conserved Toll-like receptor signaling potential in embryonic myeloid leukocytes and adult immune cell lineages.
    Hall C; Flores MV; Chien A; Davidson A; Crosier K; Crosier P
    J Leukoc Biol; 2009 May; 85(5):751-65. PubMed ID: 19218482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of Nod-like receptors alters inflammatory response to infection but does not confer protection in experimental cerebral malaria.
    Finney CA; Lu Z; LeBourhis L; Philpott DJ; Kain KC
    Am J Trop Med Hyg; 2009 May; 80(5):718-22. PubMed ID: 19407112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatase PTP1B negatively regulates MyD88- and TRIF-dependent proinflammatory cytokine and type I interferon production in TLR-triggered macrophages.
    Xu H; An H; Hou J; Han C; Wang P; Yu Y; Cao X
    Mol Immunol; 2008 Aug; 45(13):3545-52. PubMed ID: 18571728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Destructive role of myeloid differentiation factor 88 and protective role of TRIF in interleukin-17-dependent arthritis in mice.
    Abdollahi-Roodsaz S; van de Loo FA; Koenders MI; Helsen MM; Walgreen B; van den Bersselaar LA; Arntz OJ; Takahashi N; Joosten LA; van den Berg WB
    Arthritis Rheum; 2012 Jun; 64(6):1838-47. PubMed ID: 22147588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection.
    McKay D; Shigeoka A; Rubinstein M; Surh C; Sprent J
    Eur J Immunol; 2006 Aug; 36(8):1994-2002. PubMed ID: 16874736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.